[HTML][HTML] Expression of suppressors of cytokine signaling during liver regeneration

JS Campbell, L Prichard, F Schaper… - The Journal of …, 2001 - Am Soc Clin Investig
JS Campbell, L Prichard, F Schaper, J Schmitz, A Stephenson-Famy, ME Rosenfeld…
The Journal of clinical investigation, 2001Am Soc Clin Investig
The cytokines TNF and IL-6 play a critical role early in liver regeneration following partial
hepatectomy (PH). Since IL-6 activates signal transducers and activators of transcription
(STATs), we examined whether the suppressors of cytokine signaling (SOCS) may be
involved in terminating IL-6 signaling. We show here that SOCS-3 mRNA is induced 40-fold
2 hours after surgery. SOCS-2 and CIS mRNA are only weakly induced, and SOCS-1 is not
detectable. SOCS-3 induction after PH is transient and correlates with a decrease in STAT-3 …
The cytokines TNF and IL-6 play a critical role early in liver regeneration following partial hepatectomy (PH). Since IL-6 activates signal transducers and activators of transcription (STATs), we examined whether the suppressors of cytokine signaling (SOCS) may be involved in terminating IL-6 signaling. We show here that SOCS-3 mRNA is induced 40-fold 2 hours after surgery. SOCS-2 and CIS mRNA are only weakly induced, and SOCS-1 is not detectable. SOCS-3 induction after PH is transient and correlates with a decrease in STAT-3 DNA binding and a loss of tyrosine 705 phosphorylation. This response is markedly reduced in IL-6 knockout (KO) mice. TNF injection induces SOCS-3 mRNA in wild-type mice (albeit weakly compared with the increase observed after PH) but not in TNF receptor 1 or IL-6 KO mice. In contrast, IL-6 injection induces SOCS-3 in these animals, demonstrating a requirement for IL-6 in SOCS-3 induction. IL-6 injection into wild-type mice also induces SOCS-1, -2, and CIS mRNA, in addition to SOCS-3. Together, these results suggest that SOCS-3 may be a key component in downregulating STAT-3 signaling after PH and that SOCS-3 mRNA levels in the regenerating liver are regulated by IL-6.
The Journal of Clinical Investigation